Nordic News, Business and Life in Asia
Danish pharmaceutical company Novo Nordisk has announced plans to invest an additional 200 million yuan (US$29.4 million) in its production facility in Tianjin, China, expanding both drug manufacturing and injection …
Novo Nordisk invests further in Tianjin production hub Read More
Danish pharmaceutical giant Novo Nordisk has announced a new 800-million-yuan (approximately USD 111.9 million) investment to expand its quality-control laboratory in Tianjin, China. The memorandum of cooperation was signed …
Novo Nordisk invests USD 111.9 million to expand Tianjin facility Read More
Danish pharmaceutical giant Novo Nordisk is striving to increase capacity for its blockbuster medications, Ozempic and Wegovy. To ramp up production, Novo Nordisk will focus on hiring outside of Denmark, …
Novo Nordisk expands footprint in China with recruitment shift Read More
Novo Nordisk has officially launched its weight loss medication Wegovy in China. This move opens access to over 500 million potential candidates for treatment by 2045. Regulatory approval and market …
Novo Nordisk launches Wegovy in China Read More
The popular weight loss medicin Wegovy by the Danish phamaceutical firm Novo Nordisk has been approved for consumers in China. This has been confirmed by an employee at the company. …
Wegovy approved in China Read More